167 related articles for article (PubMed ID: 28615288)
1. Correlation between Apparent Substrate Affinity and OCT2 Transport Turnover.
Severance AC; Sandoval PJ; Wright SH
J Pharmacol Exp Ther; 2017 Sep; 362(3):405-412. PubMed ID: 28615288
[TBL] [Abstract][Full Text] [Related]
2. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.
Belzer M; Morales M; Jagadish B; Mash EA; Wright SH
J Pharmacol Exp Ther; 2013 Aug; 346(2):300-10. PubMed ID: 23709117
[TBL] [Abstract][Full Text] [Related]
3. Unstirred Water Layers and the Kinetics of Organic Cation Transport.
Shibayama T; Morales M; Zhang X; Martínez-Guerrero LJ; Berteloot A; Secomb TW; Wright SH
Pharm Res; 2015 Sep; 32(9):2937-49. PubMed ID: 25791216
[TBL] [Abstract][Full Text] [Related]
4. Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2.
Sandoval PJ; Morales M; Secomb TW; Wright SH
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F720-F734. PubMed ID: 31313952
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates.
Sandoval PJ; Zorn KM; Clark AM; Ekins S; Wright SH
Mol Pharmacol; 2018 Sep; 94(3):1057-1068. PubMed ID: 29884691
[TBL] [Abstract][Full Text] [Related]
6. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.
Harper JN; Wright SH
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F56-67. PubMed ID: 23034939
[TBL] [Abstract][Full Text] [Related]
8. Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
Hacker K; Maas R; Kornhuber J; Fromm MF; Zolk O
PLoS One; 2015; 10(9):e0136451. PubMed ID: 26327616
[TBL] [Abstract][Full Text] [Related]
9. Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in
Kuehne A; Floerl S; Hagos Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555439
[TBL] [Abstract][Full Text] [Related]
10. Functional mapping of rbOCT1 and rbOCT2 activity in the S2 segment of rabbit proximal tubule.
Kaewmokul S; Chatsudthipong V; Evans KK; Dantzler WH; Wright SH
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1149-59. PubMed ID: 12944320
[TBL] [Abstract][Full Text] [Related]
11. Transport Turnover Rates for Human OCT2 and MATE1 Expressed in Chinese Hamster Ovary Cells.
Zhang X; Wright SH
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163393
[TBL] [Abstract][Full Text] [Related]
12. Functional map of TEA transport activity in isolated rabbit renal proximal tubules.
Wright SH; Evans KK; Zhang X; Cherrington NJ; Sitar DS; Dantzler WH
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F442-51. PubMed ID: 15126247
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes.
Song IS; Shin HJ; Shin JG
Xenobiotica; 2008 Sep; 38(9):1252-62. PubMed ID: 18728938
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells.
Wongwan T; Chatsudthipong V; Soodvilai S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846898
[TBL] [Abstract][Full Text] [Related]
15. Novel method for kinetic analysis applied to transport by the uniporter OCT2.
Wright SH; Secomb TW
Am J Physiol Renal Physiol; 2022 Sep; 323(3):F370-F387. PubMed ID: 35862650
[TBL] [Abstract][Full Text] [Related]
16. The multidrug transporter MATE1 sequesters OCs within an intracellular compartment that has no influence on OC secretion in renal proximal tubules.
Martínez-Guerrero LJ; Evans KK; Dantzler WH; Wright SH
Am J Physiol Renal Physiol; 2016 Jan; 310(1):F57-67. PubMed ID: 26538438
[TBL] [Abstract][Full Text] [Related]
17. Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants.
Fujita T; Urban TJ; Leabman MK; Fujita K; Giacomini KM
J Pharm Sci; 2006 Jan; 95(1):25-36. PubMed ID: 16307453
[TBL] [Abstract][Full Text] [Related]
18. Lack of Influence of Substrate on Ligand Interaction with the Human Multidrug and Toxin Extruder, MATE1.
Martínez-Guerrero LJ; Morales M; Ekins S; Wright SH
Mol Pharmacol; 2016 Sep; 90(3):254-64. PubMed ID: 27418674
[TBL] [Abstract][Full Text] [Related]
19. Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+.
Thévenod F; Ciarimboli G; Leistner M; Wolff NA; Lee WK; Schatz I; Keller T; Al-Monajjed R; Gorboulev V; Koepsell H
Mol Pharm; 2013 Aug; 10(8):3045-56. PubMed ID: 23763587
[TBL] [Abstract][Full Text] [Related]
20. A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2).
Zhang X; Shirahatti NV; Mahadevan D; Wright SH
J Biol Chem; 2005 Oct; 280(41):34813-22. PubMed ID: 16087669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
